Announcements

NXP Semiconductors N.V. EVP and CFO William Betz filed a Form 4 on November 9, 2026, disclosing two restricted stock unit vesting events and related tax-withholding disposals of common stock on November 5 and November 7, 2026.

Shereen Solaiman, Chief People Officer of Myriad Genetics Inc, filed a statement of changes in beneficial ownership on November 9, 2026, disclosing a grant of 83,049 time-based stock options on November 6, 2026.

Benjamin Richard Wheeler, Chief Financial Officer of Myriad Genetics Inc, filed a Form 4 on November 9, 2026, disclosing the acquisition of a time-based stock option covering 121,379 shares of common stock granted on November 6, 2026.

Myriad Genetics Inc Chief Operating Officer Mark Verratti filed a Form 4 on November 9, 2026, disclosing the acquisition of 146,933 time-based stock options granted on November 6, 2026, as a retention award under the company's 2026 Employee, Director and Consultant Equity Incentive Plan.

Dale Muzzey, Chief Scientific Officer of Myriad Genetics Inc, filed a Form 4 on November 9, 2026, disclosing the acquisition of 92,632 time-based stock options granted as a one-time retention award on November 6, 2026.

A Form 4 filed on November 9, 2026 discloses that Jennifer Lynne Fox, Chief Legal and Corporate Strategy Officer at Myriad Genetics Inc, was granted 139,267 time-based stock options on November 6, 2026 as a one-time retention award.

RLI Corp Chief Executive Officer Craig W. Kliethermes filed an amended ownership statement on November 9, 2026, correcting the reported amount of stock options granted to him on November 2, 2026.